Nuo Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nuo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Nuo Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -347 %, a 17.8% decline year-over-year.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2023 was -355 %, a 164% decline from 2022.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2022 was -135 %, a 186% decline from 2021.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2021 was 156 %, a 1424% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -355 -220 -164% Jan 1, 2023 Dec 31, 2023
2022 -135 -290 -186% Jan 1, 2022 Dec 31, 2022
2021 156 +146 +1424% Jan 1, 2021 Dec 31, 2021
2020 10.2 -98.5 -90.6% Jan 1, 2020 Dec 31, 2020
2019 109 -441 -80.2% Jan 1, 2019 Dec 31, 2019
2018 550 +775 Jan 1, 2018 Dec 31, 2018
2017 -225 Jan 1, 2017 Dec 31, 2017
2015 -2.6K -2.49K -2258% Jan 1, 2015 Dec 31, 2015
2014 -110 -48.9 -79.6% Jan 1, 2014 Dec 31, 2014
2013 -61.5 -1.23 -2.04% Jan 1, 2013 Dec 31, 2013
2012 -60.3 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.